Efficacy and safety of sofosbuvir-based therapies for treating HCV in children: observations from a real-world setting. [PDF]
Pokorska-Śpiewak M +4 more
europepmc +1 more source
A cost-utility analysis of Glecaprevir/Pibrentasvir versus Sofosbuvir/Daclatasvir and Sofosbuvir/Velpatasvir for treatment of hepatitis C in Iran. [PDF]
Jafari M +6 more
europepmc +1 more source
Community-based integrated care for HIV, viral hepatitis and sexually transmitted infections, Thailand. [PDF]
Wansom T +36 more
europepmc +1 more source
Pharmacokinetics of Sofosbuvir and Velpatasvir for Hepatitis C Treatment in Pregnancy. [PDF]
Giles ML +7 more
europepmc +1 more source
Impact of a pharmacist-led hepatitis C clinic on hepatitis A and B vaccination rates and treatment outcomes: A retrospective cohort study. [PDF]
Jenkins L +4 more
europepmc +1 more source
Viral hepatitis after liver transplantation: A brief overview. [PDF]
Praharaj DL +8 more
europepmc +1 more source
A single center experience of concomitant administration of sofosbuvir/velpatasvir and amiodarone after heart and lung transplantation. [PDF]
Rivosecchi RM +5 more
europepmc +1 more source
Budget impact analysis of glecaprevir/pibrentasvir treatment for hepatitis C in Iran: a modelling study. [PDF]
Jafari M +5 more
europepmc +1 more source
Sofosbuvir and Velpatasvir: A complete pan-genotypic treatment for HCV patients
Alp Serhat Kahveci, Veysel Tahan
doaj +1 more source

